The long-term investor command center. One ticker, the whole case — a Quality / Value / Momentum / Smart-Money read on top of valuation-in-context, ROIC & moat, dividend health, trend, financial health, and who’s buying. Built only from SEC filings and end-of-day prices. Glass-box, no invented numbers.
Building ATNM’s long-term case…
Pulling SEC filings
Parsing XBRL fundamentals
Scoring quality, value & momentum
Checking who’s buying
Rendering
ATNM
ACTINIUM PHARMACEUTICALS, INC.Small cap · $30.3M · FY ending 2025-12-31
●Bankruptcy-risk zoneAltman Z-Score is in the distress zone (-12.01).
●Weak fundamentalsPiotroski F-Score of 2/9 — most quality checks are failing.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.